Lurasidone Hydrochloride

CAS 367514-88-3 35 current records 1 historicalSmall Molecule

Who holds supplier records for Lurasidone Hydrochloride? 35 organisations hold a current record for Lurasidone Hydrochloride: an active US FDA Type II Drug Master File. A further 1 organisation has only historical (inactive) DMF filings. Recorded organisation countries for current records: India (26), Italy (3), Japan (1), Netherlands (1) and 1 other country (1); not recorded for 3.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Lurasidone Hydrochloride: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/lurasidone-hydrochloride

Reading the evidence

  • 35 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    26 of the 32 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 20 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (35)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Lurasidone Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Lurasidone Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (1)

Organisations whose Type II DMFs for Lurasidone Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 1 historical record
  • Apotex Pharmachem India Pvt. Ltd.
    India · Inactive DMF 28076 · filed Apr 2014

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Lurasidone Hydrochloride is an atypical antipsychotic used in the treatment of schizophrenia and bipolar depression. It functions by modulating dopamine and serotonin receptor activity in the brain.

Chemical identity

IUPAC name
(1R,2S,6R,7S)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione;hydrochloride
Canonical SMILES
C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O.Cl
InChIKey
NEKCRUIRPWNMLK-SCIYSFAVSA-N
Synonyms
Latuda API, lurasidone hcl, sm-13496

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Atypical Antipsychotic

Therapeutic areas

PsychiatryMental HealthNeurology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Lurasidone Hydrochloride?

35 organisations hold an active US FDA Type II Drug Master File or a CEP for Lurasidone Hydrochloride: Alembic Pharmaceuticals Limited (India), ALIVUS LIFE SCIENCES LTD (India), Alkem Laboratories Limited (India), ALP PHARM BEIJING CO LTD, AMSA SPA (Italy), APITORIA PHARMA PRIVATE LTD (India), Arene Life Sciences Limited (India) and Biocon Limited (India), and 27 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Lurasidone Hydrochloride Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 30092), ALIVUS LIFE SCIENCES LTD (DMF 27452), Alkem Laboratories Limited (DMF 39570), ALP PHARM BEIJING CO LTD (DMF 27584), AMSA SPA (DMF 27898), APITORIA PHARMA PRIVATE LTD (DMF 28448), Arene Life Sciences Limited (DMF 44580) and Biocon Limited (DMF 39574) and 27 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Lurasidone Hydrochloride records mean?

1 organisation has only inactive Type II DMFs for Lurasidone Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Lurasidone Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Lurasidone Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.